Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Vertex

Promising new gene therapies for sickle cell are out of reach in countries where they're needed most

New gene therapies promise a cure for sickle cell disease but experts say they are out of reach in places that need them the most

The Independent UK

Vertex Breaks Out To Record High As It Takes On Opioids In Pain Treatment

Vertex solidified its potential for an alternative to opioids in pain treatment, an analyst said Wednesday. VRTX stock broke out.

Investors Business Daily

Vertex Stock Breaks Out On Phase 2 Results For Opioid Alternative

Vertex stock rallied 13% Wednesday after reporting "statistically significant" results in a Phase 2 study for a pain drug.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

The Guardian view on cystic fibrosis treatments: a rollercoaster ride for the sick

Editorial: Patients are facing shorter lives as drug companies are demanding prices that health services here and in other countries cannot pay

The Guardian - UK

Vertex 2024 tickets now on sale!

VFX, game art, animation and more – grab your tickets to 2024's ultimate new event for the CG art community.

Creative Bloq

The world's 1st CRISPR therapy has just been approved. Here's everything you need to know

U.K. regulators have approved the use of a CRISPR therapy called Casgevy to treat two inherited blood disorders. But what is it and how does it work?

LiveScience

Vertex, the ultimate event for 2D and 3D artists, returns in 2024

The Vertex festival of digital art, VFX and animation is back in 2024.

Creative Bloq

Read news from The Economist, FT, and more,
with one subscription

Crispr Surges After Winning The First-Ever Approval For A CRISPR-Based Gene-Editing Drug

In a world first, regulators in the UK approved Crispr's gene-editing treatment for two blood diseases on Thursday, and CRSP stock surged.

Investors Business Daily

Shark Stratos vs Vertex – which clinches best vacuum cleaner?

The decision between Shark Stratos vs Vertex can seem tricky. Shark vacuums are some of the best on the market. Here's what our expert tests revealed.

Homes & Gardens

‘Life-changing’ cystic fibrosis drugs approved for use in younger children

Campaigners welcomed the announcement by the Medicines and Healthcare Products Regulatory Agency.

The Independent UK

Dow Jones Futures Rise: What To Do As Market Pulls Back; Nvidia, Tesla At Key Levels

The S&P 500 win streak is over, on higher Treasury yields and Fed chief Powell comments. Nvidia, Tesla fell from key levels.

Investors Business Daily

Vertex Slouches After Tech Leader Reports Mixed Results; But Late-Stage Pipeline In Focus

VRTX stock investors are closely watching Vertex's efforts in pain treatment, analysts said Tuesday following mixed third-quarter sales.

Investors Business Daily

Crispr Therapeutics Rallies On Bullish Views Of First-Ever Gene-Editing Drug

The FDA appears likely to approve Crispr's gene-editing approach to sickle cell disease, analysts said Wednesday as CRSP stock gapped higher.

Investors Business Daily

Dow Jones Futures Rise: Jobs Report Due; Tesla Cuts Model 3, Y Prices Again

The jobs report is key for a struggling market rally attempt. Tesla cut Model 3 and Model Y prices again.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Crispr Therapeutics, And CRISPR Gene-Editing, Face Their Make-Or-Break Moment

Crispr is facing its make-or-break moment and, experts say, a pivotal decision in December could spark more than just beleaguered CRSP stock.

Investors Business Daily

Meta Stock Leads 5 Names Showing Resilience In Market Downturn

Meta leads five resilient stocks worth watching. But investors need to be patient amid the market correction.

Investors Business Daily

Dow Jones Futures Fall; Market Correction Smashing Leaders, Is Tesla Next To Crack?

Friday's bounce fizzled, capping a grim week, with the S&P 500 hitting three-month lows. Tesla is close to breaking, but there are some stocks trying to hold up.

Guitar World

“We all loved Larry Carlton’s guitar, it was just magic… We were all looking for guitars with chunky necks, to try and get the sustain that he had”: Session legend Dean Parks reveals the secrets of his most iconic Steely Dan and Eric Clapton guitar parts

You can hear Parks on Josie, Haitian Divorce, Change the World, Rikki Don’t Lose That Number and innumerable other songs – here, the guitarist unpacks the gear and recording sessions that forged them

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Futures Fall On U.S. Debt Downgrade; AMD, ELF Lead 7 Earnings Movers

Futures fell as Fitch downgraded the U.S. debt rating. AMD and ELF Beauty were big earnings movers late

Investors Business Daily

Vertex Stock Surges As Investors Eye Its Chockfull Calendar Of Expected Drug News

Vertex Pharmaceuticals faces numerous catalysts this year and next, an analyst said Wednesday. And VRTX stock popped.

Evening Standard

Best military watches for no-nonsense aesthetics, durability and practicality

Whether you’re a soldier or a civvie, these timepieces are built for any situation

Investors Business Daily

Crispr Stock Slips; The FDA Could Approve The First CRISPR-Based Gene-Editing Drug In Just Six Months

The FDA could approve Crispr Therapeutics' gene-edited sickle cell treatment as early as December. In response, CRSP stock surged Friday.

Investors Business Daily

Vertex Stock Flirts With Buy Point On Steady Growth Prospects

Vertex is the IBD Stock Of The Day as the maker of corporate tax compliance software shows its resilience in an unstable market.

Zenger

A Middle Age Woman Copes With Cystic Fibrosis As She Prays For A Miracle

Vertexs has been present in South Africa as the young patient copes with the high cost of the medication.

Investors Business Daily

Vertex Extends Its Breakout On Better-Than-Expected Profit; Retains Outlook

Vertex Pharmaceuticals retained its full-year outlook and beat quarterly views, pushing VRTX stock higher early Tuesday.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations